Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for TFX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
March 31, 2026 365.53M
December 31, 2025 345.58M
September 30, 2025 592.65M
June 30, 2025 513.81M
March 31, 2025 464.52M
December 31, 2024 226.73M
September 30, 2024 470.26M
June 30, 2024 448.90M
March 31, 2024 448.53M
December 31, 2023 443.47M
September 30, 2023 425.19M
June 30, 2023 429.31M
March 31, 2023 410.02M
December 31, 2022 408.83M
September 30, 2022 391.25M
June 30, 2022 415.30M
March 31, 2022 407.16M
December 31, 2021 383.57M
September 30, 2021 399.74M
June 30, 2021 414.20M
March 31, 2021 401.11M
December 31, 2020 395.07M
September 30, 2020 390.48M
June 30, 2020 374.89M
March 31, 2020 441.71M
Date Value
December 31, 2019 418.67M
September 30, 2019 396.66M
June 30, 2019 382.14M
March 31, 2019 375.76M
December 31, 2018 366.29M
September 30, 2018 374.34M
June 30, 2018 359.12M
March 31, 2018 359.14M
December 31, 2017 345.88M
September 30, 2017 306.47M
June 30, 2017 303.70M
March 31, 2017 282.87M
December 31, 2016 271.99M
September 30, 2016 261.83M
June 30, 2016 273.53M
March 31, 2016 274.66M
December 31, 2015 262.42M
September 30, 2015 273.00M
June 30, 2015 286.37M
March 31, 2015 284.83M
December 31, 2014 273.70M
September 30, 2014 287.18M
June 30, 2014 301.72M
March 31, 2014 295.51M
December 31, 2013 295.29M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 686.43M
Boston Scientific Corp. 3.027B
Alphatec Holdings, Inc. 112.79M
Abbott Laboratories 8.21B
AngioDynamics, Inc. 45.55M